Suchergebnisse - "Systemic lupus erythematosus"

PubPharm (11)

1

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus : Results from the SLICC Inception Cohort

enthalten in: The Journal of rheumatology | 2019

von Wirestam, L. | Enocsson, H. | Skogh, T. | +43

2

Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus Erythematosus

enthalten in: The Journal of rheumatology | 2019

von Peschken, C. | Wang, Y. | Abrahamowicz, M. | +19

3

Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada

enthalten in: The Journal of rheumatology | 2018

von Keeling, S. | Bissonauth, A. | Bernatsky, S. | +5

4

Measuring Disease Activity and Damage with Validated Metrics : A Systematic Review on Mortality and Damage in Systemic Lupus Erythematosus

enthalten in: The Journal of rheumatology | 2018

von Keeling, S. | Vandermeer, B. | Medina, J. | +6

5

More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus

enthalten in: The Journal of rheumatology | 2018

von Pakchotanon, R. | Gladman, D. | Su, J. | +1

ErratumIn: J Rheumatol. 2019 Nov;46(11):1548. - PMID 31676547

6

Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus

enthalten in: The Journal of rheumatology | 2016

von Mora, C. | Medina-Rosas, J. | Santos, A. | +5

7

Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy

enthalten in: The Journal of rheumatology | 2016

von Durcan, L. | Winegar, D. | Connelly, M. | +3

8

SLEDAI-2K Does Not Conceal Worsening in a Particular System When There Is Overall Improvement

enthalten in: The Journal of rheumatology | 2015

von Touma, Z. | Gladman, D. | Su, J. | +2

9

Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus

enthalten in: The Journal of rheumatology | 2015

von Steiman, A. | Urowitz, M. | Ibañez, D. | +3

10

Deregulated NLRP3 and NLRP1 inflammasomes and their correlations with disease activity in systemic lupus erythematosus

enthalten in: The Journal of rheumatology | 2014

von Yang, Q. | Yu, C. | Yang, Z. | +7